(Read Only) Camposano_Cardiology_book_temp 16/02/2010 10:11 Page 84
Epilepsy
1. Guberman A, Vigabatrin, Can J Neurol Sci, 1996;23:S13–17. treated by vigabatrin in tuberous sclerosis patients, Epilepsy Epilepsia, 2006;47:311–17.
2. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D, Res, 2000;38:151–60. 33. Westall CA, Logan WJ, Smith K, et al., The hospital for sick
Treatment of pediatric epilepsy: European expert opinion, 18. Guberman A, Bruni J, Long-term open multicentre, add-on children, toronto, longitudinal ERG study of children on
2007, Epileptic Disord, 2007;9:353–412. trial of vigabatrin in adult resistant partial epilepsy. the vigabatrin, Doc Ophthalmol, 2002;104:133–49.
3. Parisi P, Bombardieri R, Curatolo P, Current role of canadian vigabatrin study group, Seizure, 2000;9:112–18. 34. Werth R, Schadler G, Visual field loss in young children and
vigabatrin in infantile spasms, Europ J Paediatr Neurol, 19. Mitchell WG, Shah NS, Vigabatrin for infantile spasms, Pediatr mentally handicapped adolescents receiving vigabatrin,
2007;11:331–6. Neurol, 2002;27:161–4. Invest Ophthalmol Vis Sci, 2006;47:3028–35.
4. Desguerre I, Nabbout R, Dulac O, The management of 20. Lux AL, Edwards SW, Hancock E, et al., The United Kingdom 35. Ponjavic V, Andreasson S, Multifocal ERG and full-field ERG
infantile spasms, Arch Dis Child, 2008;93:462–3. infantile spasms study comparing vigabatrin with in patients on long-term vigabatrin medication, Doc
5. Riikonen R, Infantile spasms: therapy and outcome, J Child prednisolone or tetracosactide at 14 days: a multicentre, Ophthalmol, 2001;102:63–72.
Neurol, 2004;19:401–4. randomised controlled trial, Lancet, 2004;364:1773–8. 36. Spencer EL, Harding GF, Examining visual field defects in the
6. Riikonen R, The latest on infantile spasms, Curr Opin Neurol, 21. Camfield P, Camfield C, Lortie A, Darwish H, Infantile paediatric population exposed to vigabatrin, Doc Ophthalmol,
2005;18:91–5. spasms in remission may reemerge as intractable epileptic 2003;107:281–7.
7. Hancock EC, Osborne JP, Edwards SW, Treatment of spasms, Epilepsia, 2003;44:1592–5. 37. Harding GF, Wild JM, Robertson KA, et al., Separating the
infantile spasms, Cochrane Database Syst Rev, 2008:001770. 22. Wild JM, Ahn HS, Baulac M, et al., Vigabatrin and epilepsy: retinal electrophysiologic effects of vigabatrin: treatment
8. Wheless JW, Ramsay RE, Collins SD, Vigabatrin, Neurother, lessons learned, Epilepsia, 2007;48:1318–27. versus field loss, Neurology, 2000;55:347–52.
2007;4:163–72. 23. Kroll-Seger J, Kaminska A, Moutard ML, et al., Severe 38. Harding GF, Robertson K, Spencer EL, Holliday I, Vigabatrin;
9. Lux AL, Edwards SW, Hancock E, et al., The United Kingdom relapse of epilepsy after vigabatrin withdrawal: for how long its effect on the electrophysiology of vision, Doc Ophthalmol,
infantile spasms study (UKISS) comparing hormone should we treat symptomatic infantile spasms?, Epilepsia, 2002;104:213–29.
treatment with vigabatrin on developmental and epilepsy 2007;48:612–13. 39. Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE,
outcomes to age 14 months: a multicentre randomised trial, 24. Nabbout R, Melki I, Gerbaka B, et al., Infantile spasms in Detecting vigabatrin toxicity by imaging of the retinal nerve
Lancet, 2004;364(9447):1773–8. Down syndrome: good response to a short course of fiber layer, Invest Ophthalmol Vis Sci, 2006;47:917–24.
10. Elterman RD, Shields WD, Mansfield KA, Nakagawa J, US vigabatrin, Epilepsia, 2001;42:1580–83. 40. Durnian JM, Clearkin LG, Retinal nerve fibre layer
Infantile Spasms Vigabatrin Study Group, Randomized trial 25. Capovilla G, Beccaria F, Montagnini A, et al., Short-term characteristics with vigabatrin-associated visual field loss—
of vigabatrin in patients with infantile spasms, Neurology, nonhormonal and nonsteroid treatment in west syndrome, could scanning laser polarimetry aid diagnosis?, Eye,
2001;57:1416–21. Epilepsia, 2003;44:1085–8. 2008;22:559–63.
11. Camposano SE, Major P, Halpern E, Thiele EA, Vigabatrin in 26. Aicardi J, Mumford JP, Dumas C, Wood S, Vigabatrin as 41. Vanhatalo S, Alen R, Riikonen R, et al., Reversed visual field
the treatment of childhood epilepsy: a retrospective chart initial therapy for infantile spasms: a European retrospective constrictions in children after vigabatrin withdrawal—true
review of efficacy and safety profile, Epilepsia, 2008;49: survey. Sabril IS investigator and peer review groups, retinal recovery or improved test performance only?, Seizure,
1186–91. Epilepsia, 1996;37:638–42. 2001;10:508–11.
12. Chiron C, Dulac O, Beaumont D, et al., Therapeutic trial of 27. Nousiainen I, Mantyjarvi M, Kalviainen R, No reversion in 42. Wheless JW, Carmant L, Bebin M, et al., Magnetic resonance
vigabatrin in refractory infantile spasms, J Child Neurol, vigabatrin-associated visual field defects, Neurology, imaging abnormalities associated with vigabatrin in patients
1991;(Suppl. 2):S52–9. 2001;57:1916–17. with epilepsy, Epilepsia, 2009;50:195–205.
13. Hancock E, Osborne JP, Vigabatrin in the treatment of 28. Kjellstrom U, Lovestam-Adrian M, Andreasson S, Ponjavic V, 43. Pearl P, Molloy-Wells E, McClintock WM, et al., MRI
infantile spasms in tuberous sclerosis: literature review, Full-field ERG and visual fields in patients 5 years after abnormalities associated with vigabatrin therapy: higher risk
J Child Neurol, 1999;14:71–4. discontinuing vigabatrin therapy, Doc Ophthalmol, in infants? Epilepsia, 2007;47(Suppl. 4):14.
14. Lux AL, Edwards SW, Hancock E, et al., The United Kingdom 2008;117:93–101. 44. Pearl PL, Vezina LG, Saneto RP, Cerebral MRI abnormalities
infantile spasms study (UKISS) comparing hormone 29. Kalviainen R, Nousiainen I, Visual field defects with associated with vigabatrin therapy, Epilepsia, 2009;50:184–94.
treatment with vigabatrin on developmental and epilepsy vigabatrin: epidemiology and therapeutic implications, 45. Desguerre I, Marti I, Valayannopoulos V, et al., Transient
outcomes to age 14 months: a multicentre randomised trial, CNS Drugs, 2001;15:217–30. magnetic resonance diffusion abnormalities in west
Lancet Neurol, 2005;4:712–17. 30. Conway M, Cubbidge RP, Hosking SL, Visual field severity syndrome: the radiological expression of non-convulsive
15. Koo B, Vigabatrin in the treatment of infantile spasms, indices demonstrate dose-dependent visual loss from status epilepticus? Dev Med Child Neurol, 2008;50:112–16.
Pediatr Neurol, 1999;20:106–10. vigabatrin therapy, Epilepsia, 2008;49:108–16. 46. Yarrington JT, Gibson JP, Dillberger JE, et al., Sequential
16. Vigevano F, Cilio MR, Vigabatrin versus ACTH as first-line 31. Vanhatalo S, Nousiainen I, Eriksson K, et al., Visual field neuropathology of dogs treated with vigabatrin, a GABA-
treatment for infantile spasms: a randomized, prospective constriction in 91 Finnish children treated with vigabatrin, transaminase inhibitor, Toxicol Pathol, 1993;21:480–89.
study, Epilepsia, 1997;38:1270–74. Epilepsia, 2002;43:748–56. 47. Gibson JP, Yarrington JT, Loudy DE, et al., Chronic toxicity
17. Jambaque I, Chiron C, Dumas C, Mumford J, Dulac O, 32. Kinirons P, Cavalleri GL, O’Rourke D, et al., Vigabatrin studies with vigabatrin, a GABA-transaminase inhibitor,
Mental and behavioural outcome of infantile epilepsy retinopathy in an irish cohort: lack of correlation with dose, Toxicol Pathol, 1990;18:225–38.
84 US NEUROLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100